These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 14976874
1. Susceptibility of Candida species to fluconazole assayed by a disk diffusion method with automated reading versus a microdilution method. Finquelievich JL, Iovannitti CA, Mujica MT, Relloso S, Carnovale S, de Elías Costa MR, Jewtuchowicz V, Espinel-Ingroff A. Rev Argent Microbiol; 2003; 35(4):214-8. PubMed ID: 14976874 [Abstract] [Full Text] [Related]
2. Disk diffusion test and E-test with enriched Mueller-Hinton agar for determining susceptibility of Candida species to voriconazole and fluconazole. Lee SC, Lo HJ, Fung CP, Lee N, See LC. J Microbiol Immunol Infect; 2009 Apr; 42(2):148-53. PubMed ID: 19597647 [Abstract] [Full Text] [Related]
4. In vitro fluconazole susceptibility of 1565 clinical isolates of Candida species evaluated by the disk diffusion method performed using NCCLS M44-A guidelines. Testore GP, Dori L, Buonomini AR, Schito GC, Soro O, Fortina G, Andreoni S, Carlone N, Tullio V, Andreoni M. Diagn Microbiol Infect Dis; 2004 Nov; 50(3):187-92. PubMed ID: 15541604 [Abstract] [Full Text] [Related]
11. Comparison of results of fluconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program. Pfaller MA, Hazen KC, Messer SA, Boyken L, Tendolkar S, Hollis RJ, Diekema DJ. J Clin Microbiol; 2004 Aug; 42(8):3607-12. PubMed ID: 15297505 [Abstract] [Full Text] [Related]
12. Influence of different susceptibility testing methods and media on determination of the relevant fluconazole minimum inhibitory concentrations for heavy trailing Candida isolates with low-high phenotype. Alp S, Sancak B, Hascelik G, Arikan S. Mycoses; 2010 Nov; 53(6):475-80. PubMed ID: 19563491 [Abstract] [Full Text] [Related]
13. Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp. Pfaller MA, Diekema DJ, Procop GW, Rinaldi MG. J Clin Microbiol; 2007 Mar; 45(3):796-802. PubMed ID: 17215344 [Abstract] [Full Text] [Related]
17. Evaluation of the disc diffusion method with a comparison study for fluconazole susceptibility of Candida strains. Kustimur S, Kalkanci A, Mansuroglu H, Senel K. Chin Med J (Engl); 2003 Apr; 116(4):633-6. PubMed ID: 12875738 [Abstract] [Full Text] [Related]
18. Correlation between CLSI, EUCAST and Etest methodologies for amphotericin B and fluconazole antifungal susceptibility testing of Candida spp. clinical isolates. Claudino AL, Peixoto RF, Melhem MS, Szeszs MW, Lyon JP, Chavasco JK, Franco MC. Pharmazie; 2008 Apr; 63(4):286-9. PubMed ID: 18468388 [Abstract] [Full Text] [Related]
19. [Comparison of the results of in vitro antifungal susceptibility testing using the Fungitest kit and the disc diffusion test]. Buchta V, Navrátilová L, Förstl M, Kubanová P. Klin Mikrobiol Infekc Lek; 2004 Apr; 10(2):80-7. PubMed ID: 15146386 [Abstract] [Full Text] [Related]
20. Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program. Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Diekema DJ, ARTEMIS DISK Global Antifungal Surveillance Group. Diagn Microbiol Infect Dis; 2009 Sep; 65(1):27-34. PubMed ID: 19679232 [Abstract] [Full Text] [Related] Page: [Next] [New Search]